Skip to Content

User Reviews for Enfortumab vedotin to treat Urothelial Carcinoma

Also known as: Padcev

Southside · Taken for less than 1 month April 28, 2020

Padcev (enfortumab vedotin): “Severe reaction to the medicatiom Padcev . Suffering blisters all over my body that bleed profusely. No one has answered questions how long medication remains in system after discontinued.”

1 / 10

This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.

Learn more about Urothelial Carcinoma

IBM Watson Micromedex